Address: KPMG Gebouw, Laan van Langerhuize 1, 1186 DS Amstelveen, the Netherlands
Tel: +31 20 656 78 90
Web: http://www.kpmg.com/nl/nl/Pages/default.aspx
KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 140,000 outstanding professionals working together to deliver value in 146 countries worldwide.
KPMG has 15 offices in the Netherlands. We are located throughout the country, in order to be close to our clients. Our modern, sustainable headquarters is based in Amstelveen.
As from 1 October 2009, KPMG the Netherlands is part of KPMG Europe LLP, a combination of forces that currently includes the British, German, Belgian, Luxembourg, Swiss, Spanish, Russian and Turkish KPMG practices. Together these firms have approximately 30,000 partners and staff members working from more than 100 offices. In 2008, turnover totalled EUR 4.6 billion.
More information about KPMG Europe LLP can be found on www.kpmg.eu.
Global healthcare systems are facing more complex challenges than ever. KPMG is committed to providing long term support to our clients as they tackle these challenges and seek to transform the way that healthcare is provided.
Some of the key issues for healthcare organizations:
Demographic change: how to care for an ageing population with increasing and changing needs.
Quality: how to deliver better outcomes, better safety and a better patient experience at lower costs.
Access: how to ensure that people get the care they need, when and where they need it.
Funding: how to access sufficient funding for operations and capital improvements during times of intense fiscal pressure.
How can we help?
With deep industry experience, insight and technical support, KPMG firms are among the leaders in delivering a broad range of audit, tax and advisory services to meet the unique needs of healthcare policy-makers, providers and payers. Our Advisory propositions revolve around five core themes:
Care System Redesign: Working across regional health ecosystems to redesign patient pathways and shift the provision of care to more appropriate settings
Organisational Architecture: Ensuring value is delivered through mergers, acquisitions, divestments, joint ventures, shared services and outsourcing arrangements
Quality and Margin Improvement: Helping organisations to adopt best practice operational models, processes and cost management capabilities in order to enhance both service quality and value for money
Health IT: Helping to leverage enabling technologies and enhance performance through systems selection, implementation project management, controls assessments, business process improvement, and change management services
‘Board Grip’: Helping to ensure Boards have the right skills, capabilities and information to lead effectively, increase confidence in systems and processes, and improve data accuracy to streamline the costs of regulation and compliance.
While doing our research we couldn’t help but notice that you are quite passionate about issues related to healthcare and an avid proponent of healthcare reform. In this vein, what…
Despite its diminutive size, the Netherlands has historically carried a large weight in the world because of certain cultural endowments: small but united, entrepreneurial, innovative, and externally oriented. During the…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration rate in Europe, a relatively small manufacturing presence and a considerably regulated market, what…
2010 was a very important year for Ferring as it marks the 60th anniversary of the company’s founding. Amongst the various commemorations this year and in hearing the collective experiences…
The Dutch affiliate of Chiesi was established in 2007 when many changes were occurring in the local industry. The new healthcare system policy went into effect and the market was…
“Two traditions one vision” was the phrase used to describe the 2005 merger that formed Daiichi Sankyo as it is today. While referring specifically to a corporate merger, its message…
Coincidentally, our meeting today comes two days after World Diabetes Day. How was this day commemorated in the Netherlands and how does it attest to the acceptance and awareness of…
Within our reports we typically like to highlight the personalities of the industry and the stories behind the executives that we meet. As you are still relatively new to Ipsen,…
In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in the Netherlands? OTC medicines…
See our Cookie Privacy Policy Here
